You just read:

GNTbm announces licensing of exclusive sales/marketing rights of anticancer drug Chidamide to Taiwan Specialty Pharma Corp. (TSPC)

News provided by

GNT Biotech & Medicals Corporation

Jun 21, 2018, 12:00 ET